Nektar Therapeutics
Clinical trials sponsored by Nektar Therapeutics, explained in plain language.
-
New drug shows promise for severe hair loss in alopecia areata trial
Disease control OngoingThis study tests an experimental drug called rezpegaldesleukin in 94 adults with severe to very severe alopecia areata, a condition causing significant hair loss. Participants receive either the drug or a placebo for 36 weeks, with an optional extension. The main goal is to measu…
Phase: PHASE2 • Sponsor: Nektar Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control OngoingThis study tests a new drug called rezpegaldesleukin for adults with moderate-to-severe eczema (atopic dermatitis). About 396 participants will receive either the drug or a placebo for 16 weeks, and those who improve may continue treatment for up to a year. The goal is to see if …
Phase: PHASE2 • Sponsor: Nektar Therapeutics • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC